Skin care and hygiene among healthcare professionals during and after the SARS-CoV-2 pandemic
- PMID: 34917384
- PMCID: PMC8669117
- DOI: 10.1177/20503121211062795
Skin care and hygiene among healthcare professionals during and after the SARS-CoV-2 pandemic
Abstract
The severe acute respiratory syndrome coronavirus 2 pandemic has necessitated enhanced protection against viral transmission among healthcare professionals, particularly relating to handwashing and personal protective equipment. Some of these requirements may persist for years to come. They bring associated concerns around skin hygiene and general care, with damage to the face and hands now a well-documented consequence among healthcare professionals. This review assesses optimal skin care during the severe acute respiratory syndrome coronavirus 2 pandemic and in the "new normal" that will follow, identifies current knowledge gaps, and provides practical advice for the clinical setting. Regular, systematic hand cleaning with soap and water or an alcohol-based hand rub (containing 60%-90% ethanol or isopropyl alcohol) remains essential, although the optimal quantity and duration is unclear. Gloves are a useful additional barrier; further studies are needed on preferred materials. Moisturization is typically helpful and has proven benefits in mitigating damage from frequent handwashing. It may be best practiced using an alcohol-based hand rub with added moisturizer and could be particularly important among individuals with pre-existing hand dermatoses, such as psoriasis and eczema. Face moisturization immediately prior to donning a mask, and the use of dressings under the mask to reduce friction, can be helpful dermatologically, but more work is required to prove that these actions do not affect seal integrity. Nonetheless, such measures could play a role in institutional plans for mitigating the dermatologic impact of transmission control measures as we exit the pandemic.
Keywords: COVID-19; Coronavirus; SARS-CoV-2; healthcare professional; skin care.
© The Author(s) 2021.
Conflict of interest statement
Declaration of conflicting interests: The author(s) declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: J.K.R. has been a consultant, investigator, and speaker for AbbVie, Allergan, Galderma, Leo Pharma, and Pfizer; is a consultant for MetaOptima Technology Inc.; and is the founder and a shareholder of Riversol Skin Care Solutions Inc. J.P.A. reports no conflicts of interest to disclose. J.D. reports no conflicts of interest to disclose. L.C.G. has been a consultant, investigator, and speaker for AbbVie, Allergan, Janssen, and La Roche-Posay, and a speaker for Johnson & Johnson and Pierre Favre. C.M. reports no conflicts of interest to disclose. V.R. has been an investigator for AbbVie, Allergan, Galderma, Leo Pharma and Pfizer, and a speaker and consultant for AbbVie, Bausch Health, Celgene, Eli Lilly, Galderma, Janssen, Leo Pharma, L’Oréal (La Roche-Posay), Novartis, Pfizer, Proctor & Gamble, and Sanofi. N.R. reports no conflicts of interest to disclose. J.-F.T. reports no conflicts of interest to disclose. M.C.W. reports no conflicts of interest to disclose. C.Z. reports no conflicts of interest to disclose. D.Z. has been a consultant, investigator, and speaker for Genentech/Roche and Sanofi Genzyme.
References
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous